Peptide Synthesis Manufacturers Technological Advancements, Revenue Diversification, Patent Expansions, Cross-border Expansion

Peptide Synthesis Market Companies and their Innovations

The global peptide synthesis market size is calculated at USD 686.59 million in 2024, grew to USD 774.06 million in 2025, and is projected to reach around USD 2277.59 million by 2034. The market is expanding at a CAGR of 12.74% between 2025 and 2034.

Top Companies in the Peptide Synthesis

• Aapptec Peptides
• AnaSpec
• Aragen Life Sciences
• Aurigene Pharmaceutical Services
• Bachem Holding
• Biomatik
• Bio-Synthesis, Inc.
• CPC Scientific
• GenScript Biotech
• LifeTein LLC
• ProteoGenix
• Sigma Aldrich
• Thermo Fisher Scientific
• USV India

Latest Announcement by Industry Leaders

Dr. Brad Pentelute, CEO of Amide Technologies, commented that the rising prevalence of cancers and metabolic disorders, with increasing investments in novel drug research and development, raises the demand for peptide therapeutics. He emphasized that the company’s advanced synthetic capabilities enable biopharma companies to rapidly develop and iterate complex peptides. He also added that the company aims to produce thousands of peptides in short timeframes to meet global demand.

Recent Developments in the Peptide Synthesis Market

• In July 2024, researchers from the University of Manchester developed a more efficient and sustainable way of using ligase enzymes to synthesize peptide-based medicines for the treatment of cancer.
• In January 2024, Vapourtec launched the Peptide-Pilot, a solid-phase peptide synthesizer for peptide synthesis, to drastically reduce the drug development cycle from weeks to hours.

Peptide Synthesis and Pharmaceutical Shipments Overview